Delivering new insights to drive personalized trials

肾脏疾病

Collaborate with a board-certified nephrologist (who is also in academia), to ensure successful trial design and execution

Engage Fortrea’s regulatory strategy and operational experts for data-driven planning

Leverage relationships with nephrology sites and trial stakeholders (such as Dialysis Organizations and Kidney Patient Advocacy Groups) to deliver timely diversity-focused recruitment

Experience matters when choosing a partner

Partner with us

过去5年来

178

Nephrology Studies

5,000+

研究中心

23,000+

患者

Dialysis and End Stage Kidney Disease (ESKD)

Glomerular Disease

Chronic Kidney Disease (CKD) and its complications

Pediatric CDK and ESKD

Renal Impairment Studies

Get the latest from Fortrea

We’re sharing our latest news, events, and publications

网络研讨会

在此注册

文章

Recent advances in the use of surrogate endpoints in kidney diseases

Read article

网络研讨会

Dr. Barbara Gillespie co-moderates the Kidney Health Initiative webinar (58 minutes)

View the recording

Why choose Fortrea for your next Nephrology trial?

Hear and apply our lessons learned across the different types of nephrology studies to understand the nuances of sites and recipe for successful trial execution in dialysis vs. rare kidney disease (e.g., Glomerular Disease) vs. common CKD (e.g., Diabetic Kidney Disease) patients
Benefit from our focused training specific to the needs of each type of nephrology study to address issues such as proper 24-hour urine collections, renal biomarker development, PRO collection and central lab monitoring
Harness the dedicated and overlapping expertise of our partners in Clinical Pharmacology Solutions and our Rare and Pediatric Disease colleagues

Renal Impairment Studies 罕见病

了解我们

Barbara S. Gillespie（医学博士、MMS、FASN） Vice President & Therapeutic Strategy Leader

认识团队成员

Your agile partner for comprehensive nephrology clinical trials

We bring extensive depth of expertise to nephrology therapeutic development. Once your trial is underway, you can rely on Fortrea's clinical trial management team to provide close communication and collaboration. We use a highly flexible clinical platform for electronic patient-reported outcomes to provide high-quality data that enables you to stay connected to the progress of your program.

作为I期至IV期临床试验管理、临床药理学、患者通道解决方案和其他支持服务的综合提供商，Fortrea与新兴及大型生物制药、医疗器材和诊断公司合作，推动全球医疗保健创新。